← Insider buys

PRGO

Perrigo Company plc · Healthcare

Insiders bought $106K of Perrigo Company plc in the last 12 months

1 insider bought on 1 day.

$106KBought, 12 mo
$0Sold, 12 mo
$2.2BMarket cap

PRGO over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

PRGO after insider buys

3 months after each buy, from the first price a copier could get.

−14.7%Average
−17.7 ptsVs S&P 500
5 of 15Higher

15 buys since 2016 with 3 months of prices.

Congress

Members reported 21 trades in PRGO since 2023.

Every filing

71 insider filings since 2016, newest first

PRGOBuy

Geoffrey M. Parker · Director

$106K+12.0%Nov 14
PRGOBuy

Abigail Lennox · EVP and CSO

$28KSep 10
PRGOBuy

Robert Willis · EVP and CHRO

$36K+4.0%Aug 22
PRGOBuy

Geoffrey M. Parker · Director

$100K+7.0%Aug 20
PRGOBuy

Eduardo Guarita Bezerra · EVP and CFO

$68K+7.0%Aug 19
PRGOBuy

Patrick Lockwood-Taylor · CEO

$100K+5.0%Aug 8
PRGOBuy

Geoffrey M. Parker · Director

$95K+7.0%May 14
PRGOSell

Katherine C. Doyle · Director

$244K−60.0%Sep 13
PRGOSell

Ronald Craig Janish · EVP, Gbl Ops, SC, CTO

$382K−34.0%Aug 28
PRGOSell

Svend Andersen · EVP, Pres CHCI

$969K−30.0%Aug 21
PRGOBuy

Svend Andersen · EVP, Pres CHCI

$28K+1.0%May 31
PRGOBuy

Alison Ives · EVP and Chief Scientific Officer

$60K+23.0%Mar 7
PRGOBuy

Alison Ives · EVP and Chief Scientific Officer

$41K+14.0%Mar 7
PRGOBuy

Alison Ives · EVP and Chief Scientific Officer

$68K+19.0%Mar 7
PRGOBuy

Robert Willis · EVP and CHRO

$165K+33.0%Mar 1
PRGOBuy

Patrick Lockwood-Taylor · CEO

$252K+86.0%Feb 29
PRGOBuy

Geoffrey M. Parker · Director

$331K+27.0%Jun 14
PRGOSell

Murray S Kessler · CEO

$7.1M−99.0%May 15
PRGOSell

James E Dillard III · EVP, Pres CSCA

$321K−26.0%Mar 14
PRGOSell

Thomas Farrington · EVP and CIO

$132K−57.0%Mar 14
PRGOSell

Ronald Craig Janish · EVP, Gbl Ops, SC, CTO

$166K−15.0%Mar 9
PRGOBuy

Geoffrey M. Parker · Director

$190K+18.0%Mar 7
PRGOSell

Grainne Quinn · EVP and Chief Medical Officer

$75K−21.0%Dec 20
PRGOSell

Thomas Farrington · EVP and CIO

$993K−100.0%Mar 16
PRGOSell

Ronald Craig Janish · EVP, Gbl Ops, SC, CTO

$145K−16.0%Mar 8
PRGOBuy

Raymond Silcock · EVP and CFO

$991K+270.0%Dec 6
PRGOBuy

Rolf A Classon · Director

$100K+19.0%Dec 3
PRGOBuy

Geoffrey M. Parker · Director

$103K+18.0%Mar 18
PRGOSell

Ronald Craig Janish · EVP, Gbl Ops, SC, CTO

$110K−14.0%Mar 11
PRGOBuy

Richard S Sorota · EVP, Pres CSCA

$327KJan 7
PRGOBuy

Theodore R. Samuels II · Director

$211K+16.0%Nov 10
PRGOBuy

Rolf A Classon · Director

$100K+24.0%Nov 10
PRGOBuy

Svend Andersen · EVP, Pres CHCI

$150K+18.0%Aug 11
PRGOSell

Thomas Farrington · EVP and CIO

$104K−11.0%May 11
PRGOSell

Ronald Craig Janish · EVP, Global Op., Supply Chain

$135K−17.0%May 11
PRGOBuy

Theodore R. Samuels II · Director

$85K+10.0%Mar 17
PRGOSell

Todd W Kingma · EVP and General Counsel

$126K−7.0%Dec 23
PRGOSell

Grainne Quinn · EVP and Chief Medical Officer

$101K−40.0%Nov 13
PRGOSell

Ronald Craig Janish · EVP, Global Op., Supply Chain

$121K−19.0%Nov 12
PRGOSell

Ronald Winowiecki · CFO

$40K−11.0%Aug 23
PRGOBuy

Theodore R. Samuels II · Director

$188K+25.0%Aug 13
PRGOBuy

Theodore R. Samuels II · Director

$229K+42.0%Nov 14
PRGOBuy

Geoffrey M. Parker · Director

$196K+51.0%Nov 13
PRGOBuy

Svend Andersen · EVP, Pres CHCI

$246K+118.0%Nov 9
PRGOBuy

Todd W Kingma · EVP and General Counsel

$205K+16.0%Nov 9
PRGOBuy

Murray S Kessler · CEO

$1.0MNov 9
PRGOBuy

Svend Andersen · EVP, Pres CHCI

$500KAug 16
PRGOBuy

Uwe Roehrhoff · CEO

$614KMar 7
PRGOSell

Todd W Kingma · EVP and General Counsel

$133K−7.0%Dec 29
PRGOBuy

John Wesolowski · EVP, Pres Rx

$60K+335.0%Dec 19
About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.